Comparison Chart Bausch Health Companies Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:08 2024-05-17 pm EDT			5-day change	1st Jan Change
6.765 ^USD	-4.31%		-1.67%	-15.65%

May. 17	Bausch Health Companies Inc. and Salix Pharmaceuticals to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	CI
May. 15	RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BAUSCH HEALTH COMPANIES INC.	Other Pharmaceuticals	-4.31%	-1.67%	-15.65%	-20.97%	-73.00%	2.48B